Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb Ischemia: The Randomized, Double-Blind, Placebo-Controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-Arterial Supplementation (JUVENTAS) Trial
Circulation - United States
doi 10.1161/circulationaha.114.012913
Full Text
Open PDFAbstract
Available in full text
Date
March 10, 2015
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)